Log in to save to my catalogue

Genome-wide association study of corticobasal degeneration identifies risk variants shared with prog...

Genome-wide association study of corticobasal degeneration identifies risk variants shared with prog...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4469997

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Corticobasal degeneration (CBD) is a neurodegenerative disorder affecting movement and cognition, definitively diagnosed only at autopsy. Here, we conduct a genome-wide association study (GWAS) in CBD cases (
n
=152) and 3,311 controls, and 67 CBD cases and 439 controls in a replication stage. Associations with meta-analysis were 17q21 at
...

Alternative Titles

Full title

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4469997

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4469997

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/ncomms8247

How to access this item